TFC Financial Management’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $24.1K | Hold |
74
| – | – | ﹤0.01% | 323 |
|
|
2025
Q1 | $20K | Hold |
74
| – | – | ﹤0.01% | 319 |
|
|
2024
Q4 | $17.4K | Hold |
74
| – | – | ﹤0.01% | 329 |
|
|
2024
Q3 | $20.4K | Buy |
74
+20
| +37% | +$5.5K | ﹤0.01% | 323 |
|
|
2024
Q2 | $13.1K | Buy |
54
+3
| +6% | +$729 | ﹤0.01% | 327 |
|
|
2024
Q1 | $7.62K | Buy |
51
+1
| +2% | +$149 | ﹤0.01% | 350 |
|
|
2023
Q4 | $9.57K | Hold |
50
| – | – | ﹤0.01% | 333 |
|
|
2023
Q3 | $8.86K | Hold |
50
| – | – | ﹤0.01% | 354 |
|
|
2023
Q2 | $9.5K | Sell |
50
-75
| -60% | -$14.2K | ﹤0.01% | 337 |
|
|
2023
Q1 | $25K | Hold |
125
| – | – | 0.01% | 291 |
|
|
2022
Q4 | $29.7K | Hold |
125
| – | – | 0.01% | 233 |
|
|
2022
Q3 | $25K | Hold |
125
| – | – | 0.01% | 237 |
|
|
2022
Q2 | $18K | Hold |
125
| – | – | 0.01% | 262 |
|
|
2022
Q1 | $20K | Hold |
125
| – | – | 0.01% | 254 |
|
|
2021
Q4 | $21K | Hold |
125
| – | – | 0.01% | 273 |
|
|
2021
Q3 | $24K | Hold |
125
| – | – | 0.01% | 254 |
|
|
2021
Q2 | $21K | Hold |
125
| – | – | 0.01% | 260 |
|
|
2021
Q1 | $18K | Hold |
125
| – | – | 0.01% | 262 |
|
|
2020
Q4 | $16K | Hold |
125
| – | – | 0.01% | 271 |
|
|
2020
Q3 | $18K | Buy |
+125
| New | +$18K | 0.01% | 240 |
|